We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KKC:GETTEXKakaku.com, Inc. Analysis

Data as of 2026-03-11 - not real-time

€9.70

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kakaku.com’s stock is trading at €9.7, sitting right at its computed resistance of €9.70 while just above the 20‑day SMA of €8.85. The 50‑day and 200‑day SMAs sit higher at €10.35 and €13.43, underscoring a bearish medium‑term backdrop. The RSI of 55 signals a neutral momentum, but the MACD histogram is positive, giving a modest bullish signal. Volume has been stable yet extremely thin (≈22 shares traded), limiting price discovery. Volatility over the past 30 days spikes at ~58%, indicating large price swings. The overall trend direction is flagged as bearish, with a historic max drawdown of –51.5%.
On the fundamentals side, revenue surged 18% YoY to ¥90.6 bn, driven by strong margins (gross 31%, operating 30%). Profitability is robust, with a 21% net margin and an ROE of 33%, well above the industry norm. The company distributes a 3.26% dividend yield, supported by a payout ratio just under 50% and ample cash (¥36.8 bn) versus modest debt (¥3.7 bn). Its PE of 17.6 trails the sector average of 18.2, suggesting a modest discount, though a PB of 5.8 hints at a premium on book value. The low computed beta (~0.06) points to minimal market‑beta exposure, while the DCF model implies a valuation far above current levels. Taken together, the fundamentals paint a picture of a high‑quality, cash‑rich business that appears undervalued relative to earnings and dividend yield.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price at resistance with bearish SMA alignment
  • Extremely thin trading volume
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and profit margins
  • Attractive dividend yield and sustainable payout
  • Price still below longer‑term moving averages

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust ROE and cash generation
  • Undervalued earnings multiple versus sector
  • Low market‑beta exposure and solid dividend

Key Metrics & Analysis

Financial Health

Revenue Growth18.20%
Profit Margin21.30%
P/E Ratio17.6
ROE32.86%
ROA20.14%
Debt/Equity6.13
P/B Ratio5.8
Op. Cash Flow€23.3B
Free Cash Flow€13.4B
Industry P/E18.2

Technical Analysis

TrendBearish
RSI55.1
Support€8.10
Resistance€9.70
MA 20€8.85
MA 50€10.35
MA 200€13.43
MACDBullish
VolumeStable
Fear & Greed Index77.32

Valuation

Fair Value€2,082.68
GradeUndervalued
TypeBlend
Dividend Yield3.26%

Risk Assessment

Beta0.06
Volatility57.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.